Original language | English |
---|---|
Pages (from-to) | 13 |
Number of pages | 1 |
Journal | Internal Medicine Journal |
Volume | 48 |
Issue number | S3 |
Publication status | Published - Apr 2018 |
Externally published | Yes |
Event | Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (48th : 2018) - Melbourne, Australia Duration: 21 Apr 2018 → 24 Apr 2018 |
Development and delivery of the immunoscintigraphic agent 67Ga-MILGA (Miltuximab™) for a first-in-human phase 1 clinical trial
N Lengkeek, M Roberts, T Pham, S Wissmeuller, D Campbell, B Walsh, Q Truong, I Greguric, J Wong, C Chandler, A Winthorpe, R Sheth, M Calvi, A Bowan, A Hawes
Research output: Contribution to journal › Meeting abstract